Lincoln, NE – HTI Plastics, a world leader in injection molded plastic, will partner with a physician researcher at the University of North Carolina at Chapel Hill’s School of Medicine to provide pharmaceutical feminine applicators for a cervical cancer treatment study in low-and-middle-income countries (LMICs).

“HTI is proud to be a partner in this important global health research study, which is an amazing opportunity to give back to the community in a small way,” said John Eby, Director of Sales and Marketing at HTI Plastics. “It is an honor to be able to contribute to research that will help women in LMICs fight cervical cancer.”

While cervical cancer’s prevalence is on the decline in high-income countries like the United States, it remains one of the most common cancers globally, with women in low- and middle-income countries (LMICs) bearing a disproportionate burden of global incidence and mortality rates. This is largely due to inadequate healthcare infrastructure and human resources in LMICs. Current cervical precancer treatment methods require a trained clinician, many of whom are inaccessible to a majority of women globally where the doctor to patient ratio is extremely low.

In response, UNC Obstetrics and Gynecology Professor Dr. Chemtai Mungo, a member of the UNC Institute for Global Health and Infectious Diseases and the UNC Lineberger Comprehensive Cancer Center, with support from the American Association of Cancer Research and the National Institute of Health, is investigating whether women in LMICs who cannot access trained doctors can use self-administered, intravaginal therapies to treat cervical precancer. Studies in the United States have demonstrated that intravaginal self-application of topical therapies including 5-fluorouracil can be safe and effective as a first-line cervical precancer treatment, or as an adjuvant treatment for women at high risk of treatment failure following traditional treatment methods.

Dr. Mungo’s studies are focused on narrowing the equity gap in global cervical cancer prevention and improving health outcomes for women in LMICs. This effort will also support the World Health Organization’s global strategy to eliminate cervical cancer by 2030, by availing cervical precancer treatment to all women.

ABOUT HTI PLASTICS
Since 1985, HTI Plastics has provided high-quality injection-molded plastic parts to customers in the U.S. and overseas, with a strong focus on both responsive expertise and exceptional value. 
HTI’s knowledgeable team is dedicated to working in partnership with customers to provide innovative solutions and timely deliveries in an atmosphere of continuous improvement. 
For more information, visit htiplastic.com.

PCE Inc., a privately held corporation founded in 1993, is structured two business groups serving the plastics industry. 
HTI Plastics providing injection molding services and Lincoln Plastics providing plastic profile extrusion services.  
PCE, Inc. does business in six continents with solutions for every size of company. www.pce.us.com